The alpha-adrenergic receptors (alpha-ARs) in canine mesenteric vein (
DMV) were studied by using nonselective agonists and selective antagon
ists in functional studies and in ligand binding to classify the subty
pes present. Based on functional studies of phenylephrine (PE)-induced
contractions and ligand-binding interactions of [H-3]-prazosin with p
razosin (PR), WB 4101 (WB), 5-methylurapidil (5-MU), BMY 7378, and SK&
F 105854, and pretreatment with chloroethylclonidine (CEC), DMV alpha(
1)-ARs resembled the alpha(1D) subtype. However, the affinity of PR as
sessed in functional and ligand-binding studies was less (PKB,D,i less
than or equal to 9) than expected from previous characterization of c
loned rat or human alpha(1-)AR (pK(i) greater than or equal to 10). In
teractions with 5-MU, BMY 7378, or SK&F 105854 suggested the presence
of some alpha(1)-ARs that were not typical of alpha(1D)-AR and that bi
nding and functional interactions did not yield corresponding results.
PR binding was abolished by treatment with CEC, contractile responses
to PE were reduced in E-max, and the concentration-effect curve shift
ed to the left, as previously reported. DMVs contracted in response to
alpha(2)-AR agonists and were studied when contractions were potentia
ted by increasing extracellular KCl to 20 mM. Rauwolscine (RAU) had K-
B values at these sites consistent with K-D values in binding studies.
CEC had no effect on RAU binding in DMV. Ligand-binding studies to [H
-3]-RAU sites did not reveal a clear identification of subtype, but th
ese alpha(2)-ARs were clearly not alpha(2B)-ARs. We conclude that cani
ne mesenteric vein contains alpha(1D)-like ARs, but with significant d
ifferences, and an unclassifiable alpha(2)-AR. There may also be a sma
ller population of other, not alpha(1D)-like ARs, receptors, mediating
responses to PE and binding of prazosin.